(Q37917992)

25 August 2017

1 reference

title

Human leukocyte antigen-G in cancer: are they clinically relevant? (English)

1 reference

25 August 2017

Human leukocyte antigen-G in cancer: Are they clinically relevant? (English)

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

9 December 2024

author name string

Wei-Hua Yan

1

1 reference

25 August 2017

language of work or name

English

0 references

publication date

22 July 2011

1 reference

full work available at URL

25 August 2017

https://api.elsevier.com/content/article/PII:S0304383511004332?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

https://api.elsevier.com/content/article/PII:S0304383511004332?httpAccept=text/plain

9 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

9 December 2024

1 reference

25 August 2017

volume

311

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

123-130

1 reference

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

25 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Strategies to counteract MHC-I defects in tumors

9 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Immune selective pressure and HLA class I antigen defects in malignant lesions

9 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands

9 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

HLA-G: from biology to clinical benefits

9 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Human leukocyte antigen-G polymorphism in relation to expression, function, and disease

9 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Biology and functions of human leukocyte antigen-G in health and sickness

9 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

The truncated cytoplasmic tail of HLA-G serves a quality-control function in post-ER compartments

9 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

The role of peptide presentation in the physiological function of HLA-G.

9 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

The tolerogenic molecule HLA-G

9 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells.

9 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis

9 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Human leukocyte antigen-G (HLA-G) as a marker for diagnosis, prognosis and tumor immune escape in human malignancies

9 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?

9 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Structural studies on HLA-G: implications for ligand and receptor binding

9 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

9 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells

9 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Inhibition of HLA-G expression via RNAi abolishes resistance of extravillous trophoblast cell line TEV-1 to NK lysis

9 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes

9 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

HLA-G has a concentration-dependent effect on the generation of an allo-CTL response

9 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4 T cells

9 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8 cells and inhibit cytotoxic T cell activity through CD8 ligation

9 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

HLA-G-dependent suppressor cells: Diverse by nature, function, and significance.

9 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells.

9 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Mechanisms of prolongation of allograft survival by HLA-G/ILT4-modified dendritic cells

9 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Tolerization of dendritic cells by HLA-G.

9 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4 CD25highFOXP3 regulatory T cells.

9 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17

9 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

9 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release

9 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism

9 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal

9 December 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?

9 December 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

What is trogocytosis and what is its purpose?

9 December 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Trogocytosis-based generation of suppressive NK cells

9 December 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Different functional outcomes of intercellular membrane transfers to monocytes and T cells.

9 December 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells

9 December 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

9 December 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

HLA-G expression in hematologic malignancies

9 December 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

HLA-G Expression in Cancers: Potential Role in Diagnosis, Prognosis and Therapy

9 December 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Exosomes bearing HLA-G are released by melanoma cells.

9 December 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

A study of human leukocyte antigen G expression in hydatidiform moles

9 December 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Expression of classic and nonclassic HLA class I antigens in uveal melanoma

9 December 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.

9 December 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer

9 December 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Human leukocyte antigen-G is expressed in advanced-stage ovarian carcinoma of high-grade histology

9 December 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma.

9 December 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro

9 December 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients

9 December 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma

9 December 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection

9 December 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Expression of HLA-G in patients with hepatocellular carcinoma

9 December 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer

9 December 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer

9 December 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma

9 December 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer

9 December 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma

9 December 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Human leukocyte antigen‐G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma

9 December 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma

9 December 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer

9 December 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma

9 December 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompati

9 December 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma

9 December 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Characterization of HLA-G expression in renal cell carcinoma

9 December 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Tumor-specific upregulation of human leukocyte antigen-G expression in bladder transitional cell carcinoma

9 December 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Expression of HLA-G in cancer bladder

9 December 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Unfavourable clinical implications for HLA-G expression in acute myeloid leukaemia

9 December 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

HLA-G expression is irrelevant to prognosis in patients with acute myeloid leukemia

9 December 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia

9 December 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?

9 December 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Prognostic irrelevance of HLA-G in B-cell chronic lymphocytic leukemia

9 December 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Expression of HLA-G in patients with B-cell chronic lymphocytic leukemia (B-CLL)

9 December 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Non-classical transcriptional regulation of HLA-G: an update

9 December 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Detection of HLA-G5 secreting cells.

9 December 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

HLA-G is a potential tumor marker in malignant ascites

9 December 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Differences in the soluble HLA-G blood serum concentration levels in patients with ovarian cancer and ovarian and deep endometriosis

9 December 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer

9 December 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Prognostic relevance of soluble human leukocyte antigen–G and total human leukocyte antigen class I molecules in lung cancer patients

9 December 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Serum sHLA-G levels: a useful indicator in distinguishing colorectal cancer from benign colorectal diseases

9 December 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Plasma soluble HLA‐G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer

9 December 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Up‐regulation of HLA‐G expression in cervical premalignant and malignant lesions

9 December 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Total Soluble HLA Class I and Soluble HLA-G in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance

9 December 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders.

9 December 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

HLA-G class I gene expression in normal and malignant hematopoietic cells

9 December 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

Serum level of soluble human leukocyte antigen-G molecules in non-Hodgkin lymphoma: does it have a prognostic value?

9 December 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2011.07.019

9 December 2024

Identifiers

1 reference

25 August 2017

1 reference